The predominance of ω-6 polyunsaturated fatty acids in cystic fibrosis despite low arachidonic acid levels [5]

Acta Paediatrica, International Journal of Paediatrics

Volumn 92, Issue 11, 2003, Pages 1354-1355

  Walkowiak, J ^a,b   Wilczynski, M ^a   Boleslawska, I ^b   Krawczynski, M ^a   Korzon, M ^c   Przyslawski, Juliusz ^b  

^a Institute of Paediatrics   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID;

ADOLESCENT; ADULT; CALORIC INTAKE; CARBOHYDRATE INTAKE; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; FAT INTAKE; FECES; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; LETTER; LIPID ANALYSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; NUTRITIONAL STATUS; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN INTAKE; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; ARACHIDONIC ACID; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FATTY ACIDS, OMEGA-6; HUMANS; LIPIDS;

EID: 0344826054     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035250310005684     Document Type: Letter

References (9)

1. Strandvik B, Brönnegard M, Gilljam H, Carlstedt-Duke J. Relation between defective regulation of arachidonic acid release and symptoms in cystic fibrosis. Scand J Gastroenterol 1988; Suppl 143: 1-4
2. Koletzko B, Schmidt E, Bremer HJ, Haug M, Harzer G. Effects of dietary long-chain polyunsaturated fatty acids on the essential fatty acid status of premature infants. Eur J Pediatr 1989; 148: 669-75
3. Walkowiak J, Przyslawski J. Five-year prospective analysis of dietary intake and clinical status in malnourished cystic fibrosis patients. J Hum Nutr Dietet 2003; 16: 225-31
4. Walkowiak J, Herzig KH, Strzykala K, Przyslawski J, Krawczynski M. Fecal elastase-1 is superior to fecal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis. Pediatrics 2001; 19: E1-7
5. 4 transfer. Blood 1988; 72: 1687-92
6. Carlstedt-Duke J, Brönnegard M, Strandvik B. Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic effect. Proc Natl Sci USA 1986; 83: 9202-6
7. Stillwell W, Jenski LJ, Crump FT, Ehringer W. Effect of docosahexaenoic acid on mouse mitochondrial membrane properties. Lipids 1997; 32: 497-506
8. Keicher U, Koletzko B, Reinhardt B. Omega-3 fatty acids suppress the enhanced production of 5-lipo-oxygenase products from polymorph neutrophil granulocytes in cystic fibrosis. Eur J Clin Invest 1995; 25: 915-9
9. Beckles Willson N, Elliott TM, Everard ML. Omega-3 fatty acids (from fish oils) for cystic fibrosis (Cochrane Review). In: The Cochrane Library 2003; Issue 2. Oxford: Update Software.